Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704 - A phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages 809-816

  Abrams, Ross A ^a   Winter, Kathryn A ^b   Regine, William F ^c   Safran, Howard ^d   Hoffman, John P ^e   Lustig, Robert ^b   Konski, Andre A ^f   Benson, Al B ^g   MacDonald, John S ^h   Rich, Tyvin A ⁱ   Willett, Christopher G ^j  

^a RUSH UNIVERSITY   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d BROWN UNIVERSITY   (United States)

^e FOX CHASE CANCER CENTER   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h ST VINCENT S COMPREHENSIVE CANCER CENTER   (United States)

ⁱ UNIVERSITY OF VIRGINIA   (United States)

^j DUKE UNIVERSITY   (United States)

more..

Author keywords

Adjuvant therapy; Chemoradiotherapy; Pancreatic adenocarcinoma; Quality assurance; Radiotherapy

Indexed keywords

ADENOCARCINOMA OF THE PANCREAS; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CHEMORADIOTHERAPY; GEMCITABINE; MEDIAN SURVIVAL; MULTI VARIATE ANALYSIS; NONHEMATOLOGIC TOXICITY; PANCREATIC ADENOCARCINOMA; PANCREATIC HEAD; RADIATION THERAPY ONCOLOGY GROUPS; RISK OF FAILURE; TREATMENT OUTCOMES; TUMOR LOCATION;

CHEMOTHERAPY; MULTIVARIANT ANALYSIS; QUALITY ASSURANCE; RADIOTHERAPY; TOXICITY; TUMORS;

DRUG PRODUCTS;

FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT FAILURE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84855827439     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.11.039     Document Type: Article

References (40)

1. E.D. Holyoke, D.M. Stablein, P.R.M. Thomas Gastrointestinal Tumor Study Group Prolongation of disease-free interval in surgically treated rectal carcinoma N Engl J Med 312 1985 1465 1472
2. M.J. O'Connell, J.A. Martenson, and H.S. Wieand Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery N Engl J Med 331 1994 502 507
3. J.E. Tepper, M. O'Connell, and D. Niedziecki Adjuvant therapy in rectal cancer: Analysis of stage, sex, and local control - final report of Intergroup 0114 J Clin Oncol 20 2002 1744 1750
4. J.S. Macdonald, S.R. Smalley, and J. Benedetti Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 2001 725 730
5. J. Neoptolemos, D. Stocken, and H. Friess A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer New Engl J Med 350 2004 1200 1208
6. H. Oettle, S. Post, and P. Neuhaus Adjuvant chemotherapy with gemcitabine versus observation in patients undergoing curative intent resection of pancreatic cancer. A multicenter randomized controlled trial JAMA 297 2007 267 277
7. C.J. Yeo, R.A. Abrams, and L.B. Grochow Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival: a prospective, single institution experience Ann Surg 225 1997 621 636
8. H. Oettle, and P. Neuhaus Adjuvant therapy in pancreatic cancer: A critical appraisal Drugs 67 2007 2293 2310
9. R.A. Abrams Comment on "adjuvant therapy in pancreatic cancer: a critical appraisal" Drugs 67 2007 2481 2485
10. J.B. Davis, B. Reiner, and A. Dusserre Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma: The dummy run Radiother Oncol 64 2002 65 73
11. H.M. Nielsen, J. Overgaard, C. Grau, and J.J. Christensen Audit of the radiotherapy in the DBCG 82 b&c trials - a validation study of the 1,538 patients randomized to postmastectomy radiotherapy Radiother Oncol 76 2005 285 292
12. M.K. Szekendi Compliance with acute MI guidelines lowers inpatient mortality J Cardiovasc Nurs 18 2003 356 359
13. Y.Y. Han, J.A. Carcillo, and M.A. Dragotta Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome Pediatrics 112 2003 793 799
14. E.D. Peterson, C.V. Pollack Jr., and M.T. Roe Early use of glycoprotein Iib/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4 J Am Coll Cardiol 42 2003 45 53
15. G. Micieli, A. Cavallini, and S. Quaglini Guideline compliance improves stroke outcome: A preliminary study in 4 districts in the Italian region of Lombardia Stroke 33 2002 1341 1347
16. W.F. Regine, K.A. Winter, and R.A. Abrams Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial JAMA 299 2008 1019 1026
17. D.R. Cox Regression models and life tables J Royal Stat Soc, Series B 34 1972 187 229
18. Agency for Healthcare Research and Quality. Your guide to choosing quality healthcare. http://www.ahrq.gov/consumer/qnt/qntqlook.htm. Accessed June 16, 2008.
19. T.S. Lawrence, A.W. Blackstock, and C. McGinn The mechanism of action of radiosensitization of conventional chemotherapeutic agents Semin Radiat Oncol 13 2003 13 21
20. M.D. Jeter, P.A. Jänne, and S. Brooks Gemcitabine-induced radiation recall Int J Radiat Oncol Biol Phys 53 2002 394 400
21. T.E. Eich, R. Engenhart-Cabillac, and K. Hansenmann Quality control of involved field radiotherapy in patients with early-favorable and early unfavorable Hodgkin's lymphoma: An analysis of the German Hodgkin Study Group Int J Radiat Biol Phys 71 2008 1419 1424
22. T.J. Fitzgerald, M. Urie, and K. Ullin Processes for quality improvement in radiation oncology clinical trials Int J Radiat Biol Phys 71 Suppl 1 2008 S76 S79
23. L.J. Peters, B. O'Sullivan, and J. Giralt Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: Results from TROG 02.02 J Clin Oncol 28 2010 2996 3001
24. R.A. Abrams, K. Lillemoe, and S. Piantadosi Continuing controversy over the adjuvant therapy of pancreatic cancer Lancet 358 2001 1565 1566
25. K.Y. Bilimoria, D.J. Bentrem, and C.Y. Ko Squamous cell carcinoma of the anal canal: Utilization and outcomes of recommended treatment in the United States Ann Surg Oncol 15 2008 1948 1958
26. N.G. Coburn, C.J. Swallow, and A. Kiss Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer Cancer 107 2006 2143 2151
27. E.A. Sijmons, M.A. van Lankveld, and P.O. Witteveen Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome Eur J Obstet Gynecol Reprod Biol 131 2007 203 208
28. Gastrointestinal Tumor Study Group Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone J Natl Cancer Inst 80 1988 751 755
29. P.J. Loehrer Sr, M.E. Lowell, and H.R. Cardenes A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201. 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition) J Clin Oncol 26 May 20 Suppl 2008 4506
30. C.A. Iacobuzio-Donahue, B. Fu, and S. Yachida DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer J Clin Oncol 27 2009 1806 1813
31. M.C. Perry, W.L. Eaton, and K.J. Propert Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung N Engl J Med 316 1987 912
32. J.P. Pignon, R. Arriagada, and D.C. Ihde A meta-analysis of thoracic radiotherapy for small-cell lung cancer N Engl J Med 327 1992 1618
33. M. Clarke, R. Collins, and S. Darby Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2005 2087
34. M. Overgaard, P.S. Hansen, and J. Overgaard Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy N Engl J Med 337 1997 949 955
35. M. Overgaard, M.B. Jensen, and J. Overgaard Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial Lancet 353 1999 1641 1648
36. T.P. Miller, S. Dahlberg, and J.R. Cassady Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma N Engl J Med 339 1998 21
37. J.D. Birkmeyer, A. Siewers, and E.V.A. Finlayson Hospital volume and surgical mortality in the United States N Engl J Med 346 2002 1128 1137
38. J.D. Birkmeyer, A. Warshaw, and S.R.G. Finlayson Relationship between hospital volume and late survival after pancreaticoduodenectomy Surgery 126 1999 178 183
39. B. Fisher, J.H. Jeong, and S. Anderson Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation N Engl J Med. 347 2002 567 575
40. R.G. Stock, A. Ho, and J.A. Cesaretti Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control Int J Radiat Oncol Biol Phys 66 2006 389 394